Concepedia
Statistics
Publications
8
Citations
422
H-Index
Active since
2014
Affiliations
Leiden University Medical Center(Current)
Oncode Institute
ISA Pharmaceuticals (Netherlands)
Delft University of Technology
Helmholtz Centre for Infection Research
Elham Beyranvand Nejad is an author at Leiden University Medical Center specializing in immunology, cancer immunotherapy, and oncology.
Publications per year
2014–2023
Tumor Eradication by Cisplatin Is Sustained by CD80/86-Mediated Costimulation of CD8+ T Cells
Elham Beyranvand Nejad, Tetje C. van der Sluis, Suzanne van Duikeren et al. · Cancer Research · 2016 · 137 citations
Medicine, Immunology, Oncology +17
Vaccine-Induced Tumor Necrosis Factor–Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death
Tetje C. van der Sluis, Suzanne van Duikeren, Suzanna Huppelschoten et al. · Clinical Cancer Research · 2014 · 89 citations · Full text
A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection
Iris N. Pardieck, Tetje C. van der Sluis, Esmé T.I. van der Gracht et al. · Nature Communications · 2022 · 53 citations · Full text
Veterinary Medicine, Immunology, Infectious Diseases +17
IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors
Elham Beyranvand Nejad, Camilla Labrie, Marit J van Elsas et al. · Journal for ImmunoTherapy of Cancer · 2021 · 47 citations · Full text
Demarcated thresholds of tumor-specific CD8 T cells elicited by MCMV-based vaccine vectors provide robust correlates of protection
Elham Beyranvand Nejad, Robert B. Ratts, Eleni Panagioti et al. · Journal for ImmunoTherapy of Cancer · 2019 · 29 citations · Full text
1–5 of 8